Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
Reducing Cardiovascular Risk in Adults With Serious Mental Illness
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia
Relative Effectiveness of Schizophrenia Therapy Study
CATIE- Schizophrenia Trial
† Indicates status has not been verified in more than two years